Novartis

Nestlé (VTX:NESN)

Discover the history and activities of Nestlé, the Swiss food giant that is constantly innovating in the areas of human and animal nutrition. From its iconic bird's nest logo to its recent initiatives in health nutrition, Nestlé positions itself as a global leader combining tradition and innovation.

Nestlé (VTX:NESN) Read More »

Foreign currency actions and currency risk (4/4)

This post is part 4 of 4 in the series Foreign Currency Stocks and Currency Risk

In this article, we explore an additional strategy to protect against currency risk beyond forex and local currency diversification. Learn how to effectively use the correlation between securities and currency movements to optimize your investment portfolio and minimize your exposure to currency fluctuations.

Foreign currency actions and currency risk (4/4) Read More »

Generations & investment (3/7): baby boomers (1943-1959)

This post is part 3 of 7 in the series Generations and investment

Baby boomers, a generation characterized by idealism and individualism according to Strauss and Howe, have a complex relationship with generations X and Y. This generation, now on the cusp of retirement, stands out for its health, its financial means and its significant impact on consumption, particularly in the area of health.

Generations & investment (3/7): baby boomers (1943-1959) Read More »

Growing dividends that beat the market (2/3)

This post is part 2 of 3 in the series Growing dividends that beat the market

In this article, we take a closer look at the dividend growth investment strategy, an approach that is particularly popular in the U.S. and gaining ground in Europe. We analyze the advantages of this method, which offers a passive source of steadily increasing income, ideal for investors seeking steady, growing returns over the long term.

Growing dividends that beat the market (2/3) Read More »

Roche (VTX:ROG)

Discover Roche, the Swiss pharmaceutical giant, world leader in cancer treatment and virology, with flagship products such as Valium and Tamiflu. The group offers an attractive yield of 3.24% and a sustained growth of its dividends, making it an interesting investment despite a higher volatility than its competitors.

Roche (VTX:ROG) Read More »